Cite
Evaluating biomarkers for prognostic enrichment of clinical trials.
MLA
Kerr, Kathleen F., et al. “Evaluating Biomarkers for Prognostic Enrichment of Clinical Trials.” Clinical Trials (London, England), vol. 14, no. 6, Dec. 2017, pp. 629–38. EBSCOhost, https://doi.org/10.1177/1740774517723588.
APA
Kerr, K. F., Roth, J., Zhu, K., Thiessen-Philbrook, H., Meisner, A., Wilson, F. P., Coca, S., & Parikh, C. R. (2017). Evaluating biomarkers for prognostic enrichment of clinical trials. Clinical Trials (London, England), 14(6), 629–638. https://doi.org/10.1177/1740774517723588
Chicago
Kerr, Kathleen F, Jeremy Roth, Kehao Zhu, Heather Thiessen-Philbrook, Allison Meisner, Francis Perry Wilson, Steven Coca, and Chirag R Parikh. 2017. “Evaluating Biomarkers for Prognostic Enrichment of Clinical Trials.” Clinical Trials (London, England) 14 (6): 629–38. doi:10.1177/1740774517723588.